MODD

Modular Medical, Inc. (MODD) Economic Moat Analysis (2026)

Invetso Score: 2.2/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Intangible Assets

Score: 2.4 (Weak)

MODD does not appear to have a durable brand, patent, or regulatory franchise that lets it charge meaningfully better prices than peers, so pricing power is likely limited.

The provided profitability metrics show negative ROIC and ROCE, which indicates the company is not converting any intangible advantage into excess returns versus peers.

With no evidence of proprietary IP or customer-recognized differentiation in the supplied data, any intangible asset base looks replicable rather than defensible.

Compared with stronger software or industrial peers that monetize protected technology or entrenched brands, MODD’s intangible moat appears materially weaker.

Switching Costs

Score:

The negative ROIC and lack of positive operating evidence suggest customers are not locked in by high switching costs that preserve margins or retention.

No filing-based evidence was provided showing mission-critical workflows, long-term contracts, or integration depth that would make replacement costly versus peers.

If switching costs were meaningful, the company would typically show more durable returns and better capital efficiency than the negative figures supplied here.

Relative to peers with embedded software, regulated platforms, or installed-base lock-in, MODD appears easy to substitute.

Network Effects

Score:

The supplied metrics do not indicate a user, data, or ecosystem flywheel that would strengthen with scale and improve retention over time.

Negative returns and zero asset turnover do not support a network-driven model where added participation compounds value versus peers.

No evidence was provided of marketplace liquidity, developer adoption, or data advantages that would create self-reinforcing demand.

Compared with peer platforms that benefit from two-sided or data network effects, MODD shows no visible network moat.

Cost Advantage

Score:

MODD’s negative ROIC and ROCE argue against a structural cost advantage, because a lower-cost producer should usually sustain superior returns versus peers.

The provided data do not show scale efficiencies, superior asset productivity, or input-cost leverage that would translate into durable margin advantage.

A cash conversion cycle that is highly negative can reflect working-capital dynamics, but by itself it does not prove a persistent cost edge over peers.

Relative to peers with manufacturing scale, procurement leverage, or process automation, MODD does not show evidence of a durable cost moat.

Efficient Scale

Score:

The available data do not show that MODD operates in a niche where one or two firms can serve the market efficiently and deter entry.

Negative returns suggest the company is not capturing the economics that usually accompany efficient-scale protection versus peers.

No evidence was provided of regulated capacity limits, local monopoly conditions, or high fixed-cost barriers that would constrain competition.

Compared with peers in utilities, infrastructure, or specialized distribution, MODD does not appear to benefit from efficient-scale insulation.

Overall Score

Score:

MODD shows no visible durable moat in the supplied evidence, as negative ROIC/ROCE and the absence of demonstrated IP, lock-in, network effects, or scale economics point to a business that is materially weaker than moat-rich peers and unlikely to sustain pricing power or retention over 5–10 years.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Modular Medical, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →